Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

259
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
259
Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

170
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
170
Generalized Anxiety Disorder01:30

Generalized Anxiety Disorder

29
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
29
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

325
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
325
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

167
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
167
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

205
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
205

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations of 24-Hour Accelerometer-Measured Movement Behaviors with Chronic Liver Disease and the Mediating Role of Proteomics and Metabolomics.

Medicine and science in sports and exercise·2026
Same author

A Synergistic Process Optimization and Data-Driven Modeling Strategy for Unraveling and Enhancing the Low-Light Response in Back-Contact Solar Cells.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same author

Structure-Guided Discovery of Neuroprotective Kromycin-Type Macrolides from <i>Streptomyces narbonensis</i> sp.

Journal of natural products·2026
Same author

Perivitelline space volume and embryonic outcomes in conventional IVF: a single-center retrospective study with mixed-effects model analysis.

Journal of ovarian research·2026
Same author

Ultra-broadband wireless rectification and frequency mixing via the nonlinear Hall effect in TaIrTe<sub>4</sub>.

Nature communications·2026

Related Experiment Video

Updated: May 10, 2025

BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain
05:17

BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain

Published on: May 26, 2023

1.1K

Long-term GABA supplementation mitigates anxiety by modulating complement and neuroinflammatory pathways.

Jiyi Xu1, Ziyu Ge1, Han Wang1

  • 1The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital & Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, 100088, China.

NPJ Science of Food
|April 24, 2025
PubMed
Summary

Oral gamma-aminobutyric acid (GABA) supplementation effectively reduced anxiety-like behaviors in mice. This therapeutic effect was linked to increased brain GABA levels and modulated immune responses, specifically complement pathways.

More Related Videos

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice
14:40

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice

Published on: October 27, 2020

17.9K
Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
05:42

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements

Published on: January 7, 2019

30.7K

Related Experiment Videos

Last Updated: May 10, 2025

BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain
05:17

BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain

Published on: May 26, 2023

1.1K
Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice
14:40

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice

Published on: October 27, 2020

17.9K
Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
05:42

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements

Published on: January 7, 2019

30.7K

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Anxiety disorders are common mental health issues associated with neuroinflammation and neurotransmitter imbalances.
  • Chronic restraint stress (CRS) is a model used to study anxiety-related conditions.

Purpose of the Study:

  • To investigate the anxiolytic effects of oral gamma-aminobutyric acid (GABA) in a mouse model of chronic restraint stress (CRS).
  • To explore the impact of GABA on neurotransmitter levels, neuroinflammation, and protein expression in the brain.

Main Methods:

  • Mice were subjected to CRS and treated with varying doses of oral GABA.
  • Anxiety-like behaviors were assessed using the elevated-plus maze and open-field tests.
  • GABA levels, anti-inflammatory cytokines (IL-10, TGF-β1), and hippocampal proteins involved in complement pathways were quantified.

Main Results:

  • GABA administration significantly reduced anxiety-like behaviors in CRS mice.
  • Oral GABA increased GABA levels in the prefrontal cortex and elevated anti-inflammatory cytokines IL-10 and TGF-β1.
  • Proteomic analysis revealed that GABA reversed stress-induced dysregulation of complement proteins (C3, C4b, Cfh, Cfi).

Conclusions:

  • Oral GABA demonstrates significant anxiolytic effects in a mouse model of chronic stress.
  • GABA's therapeutic potential may stem from its ability to restore immune homeostasis and modulate complement system activation in the brain.
  • These findings highlight GABA as a promising therapeutic agent for anxiety disorders.